On Wednesday, shares in Bowie, Maryland headquartered Inovalon Holdings Inc. ended the session 0.94% higher at $10.75 with a total volume of 933,054 shares traded. Shares of the Company, which provides cloud-based data analytics and data-driven intervention platforms in the US, are trading at a PE ratio of 38.67. The stock is trading 17.47% below its 50-day moving average and 32.55% below its 200-day moving average. Moreover, the Company's shares have a Relative Strength Index (RSI) of 41.74.
On December 20th, 2016, research firm KeyBanc Capital Markets downgraded the Company's stock rating from 'Overweight' to 'Sector Weight'. INOV complete research report is just a click away and free at:
Watertown, Massachusetts headquartered athenahealth Inc.'s stock finished Wednesday's session 0.62% higher at $118.90 with a total volume of 464,984 shares traded. athenahealth's shares have gained 23.60% in the past one month. The Company's shares are trading above its 50-day moving average by 14.95%. Shares of athenahealth, which together with its subsidiaries, provides cloud-based services and mobile applications for medical groups and health systems, are trading at a PE ratio of 252.44. The stock has an RSI of 69.32.
On January 04th, 2017, research firm KeyBanc Capital Markets upgraded the Company's stock rating from 'Sector Weight' to 'Overweight'. The complimentary report on ATHN can be downloaded at:
On Wednesday, shares in New York headquartered Medidata Solutions Inc. recorded a trading volume of 326,333 shares. The stock ended the day 1.32% lower at $52.27. Shares of the Company, which provides cloud-based solutions for life sciences worldwide, are trading at a PE ratio of 119.89. Medidata Solutions' stock gained 15.31% in the past one year. The Company is trading above its 50-day and 200-day moving averages by 0.68% and 5.84%, respectively. Furthermore, Medidata Solutions' shares have an RSI of 53.29. Sign up for your complimentary research report on MDSO at:
Irvine, California headquartered Quality Systems Inc.'s stock edged 0.51% higher, to close the day at $13.89. The stock recorded a trading volume of 246,251 shares. Quality Systems' shares have gained 26.27% in the last three months. The Company's shares are trading 3.83% and 8.38% above its 50-day and 200-day moving averages, respectively. Additionally, shares of the Company, which together with its subsidiaries, develops and markets software and services that automate various aspects of practice management and electronic health records for medical and dental practices in the US, have an RSI of 61.54. Get free access to your research report on QSII at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: +44 330 808 3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA